PROJECT

Projects

Summary of Proposed Investment

Project Number

31253

Company Name

GRANULES INDIA LIMITED

Date SPI Disclosed

Aug 11, 2011

Country

India

Industry

Health, Education and Life Sciences

Projected Board Date

Sep 12, 2011

Status

Completed

Sector

Pharmaceuticals and Medicine

Department

Gbl Ind, Manufact, Agribus & Services

Environmental Category

B - Limited

Previous Events

Approved : Sep 26, 2011
Signed : Sep 29, 2011
Invested : Dec 8, 2011

Project Description

Granules India Limited (“Granules” or the “Company”)— an existing IFC client— is a leading Contract Manufacturing Organization supplying high volume Active Pharmaceutical Ingredients, Pharmaceutical Formulation Intermediates (PFIs) and finished formulations to the bulk over-the-counter drugs industry in the US, Europe, Latin America, Australia and India. Granules has three wholly-owned manufacturing plants near Hyderabad in India (Jeedimetla, Bonthapally, and Gagillapur) and one plant in China through a 50:50 joint venture. The company is undertaking an investment program (the “Project”) estimated to cost about $22 million, comprising of: expanding the capacity of its multi-product tableting plant, expanding the capacity of its PFI plant and expanding its warehousing capacity.

Sponsor / Cost / Location

Development Impact